These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1071407

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Role of a competitive antagonist of angiotensin II (saralasin) in the diagnosis and therapy of arterial hypertension].
    Mazza F, Messore T, Catzola A, Corvino A, Genovese A, Catalano M, Mercone G.
    Recenti Prog Med; 1983 Apr; 74(4):415-29. PubMed ID: 6348901
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Saralasin infusion in renovascular and essential hypertension.
    Thien T, Hoefnagels WH.
    Neth J Med; 1980 Apr; 23(2):68-73. PubMed ID: 6990282
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Role of renin-angiotensin system in experimental hypertension in rats: plasma renin and hypotensive effect of angiotensin II antagonist.
    Yamamoto J.
    Jpn Circ J; 1977 Jun; 41(6):665-75. PubMed ID: 886656
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
    Roos JC, Geyskes GG, Boer P, Dorhout Mees EJ.
    J Cardiovasc Pharmacol; 1981 Jun; 3(5):1106-15. PubMed ID: 6168855
    [Abstract] [Full Text] [Related]

  • 33. [Significance of renin-angiotensin system inhibitors in the diagnosis of hypertension].
    Stumpe KO, Kolloch RE, Overlack A.
    Med Welt; 1977 Oct 14; 28(41):1645-9. PubMed ID: 927124
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Use of saralasin in hypertensive uremic patients under periodic hemodialysis treatment].
    Cappelli G, Vagge R, Lamperi S.
    Minerva Nefrol; 1979 Oct 14; 26(1):5-8. PubMed ID: 471322
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Plasma catecholamines and the pressor response to Sar1-Ala8-angiotensin II in man.
    McGrath BP, Ledingham JG, Benedict CR.
    Clin Sci Mol Med; 1977 Oct 14; 53(4):341-8. PubMed ID: 913058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.